Abstract : With interest we read the article by Thomas et al. about a 44 year old
female with MELAS syndrome due to the m.3243ANG mutation,
which manifested cardiologically as hypertrophic cardiomyopathy and
episodes of supraventricular tachycardia requiring atenolol [1]. We
have the following comments and concerns
https://hal-riip.archives-ouvertes.fr/pasteur-01451418
Contributor : Institut Pasteur Tunis <>
Submitted on : Wednesday, February 1, 2017 - 10:18:53 AM Last modification on : Wednesday, October 28, 2020 - 9:52:04 AM